November 24, 2021 Experience Bilibili $1.6 billion sustainable convertible notes offering The 0.5% convertible senior notes are due 2026
October 20, 2021 Experience MicroTech Medical HK$1.82 billion IPO We advised MicroTech Medical on its IPO and HKEX listing
September 10, 2021 Experience Helens HK$2.51 billion IPO We advised the underwriter on the IPO and HKEX listing
July 16, 2021 Experience Kindstar Globalgene Technology HK$2.21 billion IPO We advised Kindstar Global on its IPO and HKEX listing
July 6, 2021 Experience Zylox-Tonbridge Medical Technology HK$2.56 billion IPO We advised Zylox-Tonbridge Medical Technology on its IPO and HKEX listing
June 30, 2021 Experience Nayuki Holdings HK$5.1 billion IPO We advised Nayuki Holdings on its IPO and HKEX listing
June 21, 2021 Experience CARsgen Therapeutics HK$3.1 billion IPO We advised CARsgen Therapeutics on its IPO and HKEX listing
March 31, 2021 Experience Bairong HK$3.76 billion IPO We advised the underwriters on the IPO and HKEX listing
February 18, 2021 Experience New Horizon Health HK$2.04 billion IPO We advised New Horizon Health on its IPO and HKEX listing
February 17, 2021 Experience Akeso HK$1.19 billion share placement We advised the placing agent in the placement of new shares